Oncology PracticeVeterans’ keratinocyte carcinoma, actinic keratosis care cost $356 million in 2012September 12, 2016Practice ManagementMelanomaBusiness of Medicine
Oncology PracticePneumonitis with nivolumab treatment shows common radiographic patternsSeptember 6, 2016Lung CancerLymphoma & Plasma Cell DisordersMelanomaPatient & Survivor Care
Oncology PracticeSkip SNL biopsy for desmoplastic melanomaAugust 8, 2016MelanomaHead & Neck/Thyroid Cancers
Oncology PracticePembrolizumab-ipilimumab combo is highly active in advanced melanomaJuly 16, 2016Melanoma
Oncology PracticeSU2C announces researcher-industry collaboration on immunotherapyJuly 13, 2016Genitourinary CancerHead & Neck/Thyroid CancersMelanomaMultiple MyelomaImmuno-oncologyRenal Cell Carcinoma
Oncology PracticeStudy tracks distant metastatic patterns of Merkel cell carcinomaJuly 7, 2016MelanomaRare Diseases
Oncology PracticeStudy tracks distant metastatic patterns of Merkel cell carcinomaJuly 7, 2016MelanomaRare Diseases
The Journal of Community and Supportive OncologyEvolving therapeutic strategies maintain clinical momentum in melanomaJune 29, 2016MelanomaImmunotherapy
The Journal of Community and Supportive OncologyImplementation of ipilimumab therapy in a private practice oncology group: overcoming start-up and reimbursement issues related to expensive new cancer drugsJune 29, 2016MelanomaPractice ManagementBusiness of Medicine
Oncology PracticeCheckpoint-blocking antibodies appear safe, beneficial in elderly melanoma patientsJune 26, 2016Melanoma
Oncology PracticeImmune agonist, checkpoint inhibitor combo shows good tolerabilityJune 15, 2016Genitourinary CancerBreast CancerLung CancerMelanomaRenal Cell Carcinoma
